A Randomized, Prospective Double-Blind, Placebo-Controlled Trial of Prophylactic Oral Levofloxacin Following Chemotherapy for Lymphoma and Solid Tumors.

Trial Profile

A Randomized, Prospective Double-Blind, Placebo-Controlled Trial of Prophylactic Oral Levofloxacin Following Chemotherapy for Lymphoma and Solid Tumors.

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Levofloxacin (Primary)
  • Indications Bacterial infections
  • Focus Registrational; Therapeutic Use
  • Acronyms SIGNIFICANT
  • Most Recent Events

    • 01 Aug 2013 Additional lead trial centre added as reported by ClinicalTrials.gov record.
    • 22 May 2009 Additional trial acronym SIGNIFICANT identified as reported by United Kingdom Clinical Research Network.
    • 24 Apr 2009 sanofi aventis added as trial sponsor as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top